The Boots Company Report issue

Contributed to NME For profit Phase 4
Founded: Nottingham United Kingdom (1849)
Status: Acquired by BASF (1995) → now IG Farben (1925)

Organization Overview

First Clinical Trial
None
First Marketed Drug
1964
ibuprofen (motrin)
First NDA Approval
None
Last Known Activity
1964

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Marketed Drugs (2)

flosequinan (Manoplax) (NDA)

ibuprofen (motrin) (1964)

Drugs in Phase 4 Trials (1)

Key: The Boots Company (0) Acquired (1)

etanercept (enbrel) (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 1
  • # of Trial APIs: 1